8/15/2013

British Columbia-based Stemcell Technologies has expanded its relationship with BioLife Solutions and will use BioLife's CryoStor media with 50 new primary cell products involving peripheral blood, bone marrow, umbilical cord tissue and umbilical cord blood. The cell product portfolio is intended for use in research.

Related Summaries